Personalized Treatments in Thoracic Oncology Surgery
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Methodology, Drug and Device Discovery".
Deadline for manuscript submissions: 10 January 2026 | Viewed by 1009
Special Issue Editors
Interests: non-small-cell lung carcinoma; pulmonary metastases; vascular diseases
Special Issue Information
Dear Colleagues,
Personalized medicine diverges from standard treatment regimens by tailoring interventions to the specific factors of individual patients. While personalized medicine can be applied across various medical fields, it is particularly well-suited to oncology. The significance of personalized oncological surgery is growing. Although minimally invasive approaches are currently the preferred methods in oncological surgery, personalized treatments in thoracic surgery extend beyond these techniques. They involve adapting surgical procedures to the tumor stage and customizing neoadjuvant and adjuvant therapies. Several factors significantly influence long-term survival, which have not been sufficiently addressed by the TNM classification. These factors should also be encompassed within the concept of personalized medicine.
This Special Issue aims to elucidate current developments in personalized thoracic surgery, including segmentectomy and subsegmentectomy, and to present the latest research on particular factors influencing long-term survival. We invite submissions of the latest original research and comprehensive reviews about all aspects of thoracic oncology surgery.
Dr. Georg Schlachtenberger
Dr. Alberto Lopez
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- minimally invasive surgery
- TNM classification
- adjuvant treatment
- long-term survival
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
